"We’re in this with you, to help you get the care you need, safely. Vanderbilt Health has restarted surgeries, procedures and clinic visits that were paused or delayed. Safety is our top priority, with measures that follow – and in some cases exceed – local, state and CDC public health recommendations. Everyone wears a mask – patients, visitors, doctors, nurses and staff. We’re sanitizing rooms between each patient, and cleaning public spaces frequently throughout the day. We’re checking everyone for fever and symptoms before they enter our facilities. We’ve spaced chairs in waiting areas, limited the number who can ride elevators at once and made other changes so we can keep a safe (6 feet) physical distance."

During the past decade, Vanderbilt Hemostasis-Thrombosis Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vanderbilt Hemostasis-Thrombosis Clinic" are "Hemophilia A" (1 trials) and "Hemophilia B" (1 trials). Many other conditions were trialed in "Vanderbilt Hemostasis-Thrombosis Clinic" in a lesser frequency.

Most popular intervention types in "Vanderbilt Hemostasis-Thrombosis Clinic" are "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "DTX101" (1 trials) and "SB-525 (PF-07055480)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt Hemostasis-Thrombosis Clinic" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Vanderbilt Hemostasis-Thrombosis Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Vanderbilt Hemostasis-Thrombosis Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt Hemostasis-Thrombosis Clinic, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".